Potent factors that have been shown to modulate neutrophil tumoral bias are type I IFNs, which stimulate anti-tumor state of these cells [63], versus TGF-β [61], which stimulate pro-tumor bias. This evidence concerns the gene TGFB1 and neoplasm.